Clinical Trial Update: Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamic and pharmacokinetic study of KUC 7483 CL in patients with spinal cord injury and neurogenic detrusor overactivity; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Spinal Cord Injury

Drugs mentioned

• KUC 7483 CL (KUC 7483 CL)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Spinal Cord Injuries | Phase 1 | Status: COMPLETED